oxybutynin chloride

Generic: oxybutynin chloride

Labeler: advagen pharma limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name oxybutynin chloride
Generic Name oxybutynin chloride
Labeler advagen pharma limited
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

oxybutynin chloride 5 mg/1

Manufacturer
Advagen Pharma Limited

Identifiers & Regulatory

Product NDC 72888-030
Product ID 72888-030_48596af5-29b7-ab6c-e063-6394a90a1276
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214415
Listing Expiration 2027-12-31
Marketing Start 2020-10-27

Pharmacologic Class

Classes
cholinergic muscarinic antagonist [epc] cholinergic muscarinic antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72888030
Hyphenated Format 72888-030

Supplemental Identifiers

RxCUI
863619 863628 863636
UPC
0372888031057 0372888032016 0372888030012 0372888032054 0372888031019 0372888030050
UNII
L9F3D9RENQ

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oxybutynin chloride (source: ndc)
Generic Name oxybutynin chloride (source: ndc)
Application Number ANDA214415 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-030-01)
  • 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-030-05)
source: ndc

Packages (2)

Ingredients (1)

oxybutynin chloride (5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "48596af5-29b7-ab6c-e063-6394a90a1276", "openfda": {"upc": ["0372888031057", "0372888032016", "0372888030012", "0372888032054", "0372888031019", "0372888030050"], "unii": ["L9F3D9RENQ"], "rxcui": ["863619", "863628", "863636"], "spl_set_id": ["7bd31561-4c76-4c6b-819b-492549886673"], "manufacturer_name": ["Advagen Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-030-01)", "package_ndc": "72888-030-01", "marketing_start_date": "20201027"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-030-05)", "package_ndc": "72888-030-05", "marketing_start_date": "20240710"}], "brand_name": "Oxybutynin Chloride", "product_id": "72888-030_48596af5-29b7-ab6c-e063-6394a90a1276", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "72888-030", "generic_name": "Oxybutynin Chloride", "labeler_name": "Advagen Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxybutynin Chloride", "active_ingredients": [{"name": "OXYBUTYNIN CHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA214415", "marketing_category": "ANDA", "marketing_start_date": "20201027", "listing_expiration_date": "20271231"}